MedTrace Logo

Light Treatment for Sleep/Wake Disturbances in Alzheimer's Disease

NCT00946530 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2018-10-03

Study results available
· View outcomes & findings →

Summary

The aim of this study is to demonstrate the efficacy of timed exposure to bright light for the treatment of disturbed nighttime sleep and daytime wake in community-dwelling dementia patients and their caregivers, and to determine if there are genetic relationships between memory problems and sleep problems

Conditions

  • Sleep Initiation and Maintenance Disorders

Interventions

DEVICE

Bright light

Participants uses bright light

DEVICE

Control

Participants uses dim light

Sponsors & Collaborators

Principal Investigators

  • Jerome A Yesavage · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00946530 on ClinicalTrials.gov